Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Jul 2:346:29-40.
doi: 10.1016/j.bbr.2017.12.007. Epub 2017 Dec 8.

Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study

Affiliations
Comparative Study

Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals - A randomized double- blind pre-clinical study

Heba A Ahmed et al. Behav Brain Res. .

Abstract

Growing evidence suggests that renin angiotensin system (RAS) modulators support cognitive function in various animal models. However, little is known about their long-term effects on the brain structure in aged hypertensive animals with chronic cerebral hypoperfusion as well as which specific domains of cognition are most affected. Therefore, in the current study we examined the effects of Candesartan and Compound 21 (C21) (RAS modulators) on aspects of cognition known to diminish with advanced age and accelerate with hypertension and vascular disease. Outcome measures for sensorimotor and cognitive function were performed using a sequence of tests, all blindly conducted and assessed at baseline and after 4 and 8 weeks of chronic hypoxic hypoperfusion and treatment. Magnetic resonance imaging (MRI) was performed at the end of the 8 week study period followed by animal sacrifice and tissue collection. Both Candesartan and C21 effectively preserved cognitive function and prevented progression of vascular cognitive impairment (VCI) but only candesartan prevented loss of brain volume in aged hypertensive animals. Collectively, our findings demonstrate that delayed administration of RAS modulators effectively preserve cognitive function and prevent the development / progression of VCI in aged hypertensive animals with chronic cerebral hypoperfusion.

Keywords: AT2 Receptor; Angiotensin type 1 receptor blockade; Hypertension; MRI; Rat; Renin-angiotensin; Vascular cognitive impairment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mechanism of cognitive dysfunction induced by chronic hypertension and cerebral hypoperfusion/vascular insufficiency
Fig. 2
Fig. 2
Schematic depiction of the experimental design
Fig. 3
Fig. 3. Effect of mild cerebral hypoperfusion on the fluid intake and body weight of aged hypertensive animals
The (A) fluid intake and (B) weight trend of aged SHRs, at various time points, before and after UCCAO (n=8–10 animals/group). Symbols and error bars indicate mean and SEM, compound symmetric variance co-variance structure provided the best model fit. Differences between groups over time were examined using the estimated least squares means from a repeated measures mixed model and using a Bonferroni adjustment to the overall alpha level for the number of comparisons made between groups, any differences were nonsignificant.
Fig. 4
Fig. 4. Effect of mild cerebral hypoperfusion on the motor function of aged hypertensive animals
Swim speeds on the initial and reversal training/test of the Morris Water Maze test were taken as measures of swimming ability, a parameter of motor function (n = 8–9 animals/group). Error bars indicate SEM, Repeated measures ANOVA mixed models were used to examine differences in outcomes, for the initial training, between the groups over time. Statistical significance for post hoc comparisons using Bonferroni adjustment to the overall alpha level for the number of post hoc pair-wise comparisons, *P<0.0056, the Bonferroni adjusted alpha. For the reversal training and testing outcomes, a one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences*P<0.05. Any differences were nonsignificant.
Fig. 5
Fig. 5. Effect of RAS modulator treatment on the non-spatial working memory of aged hypertensive animals with mild cerebral hypoperfusion
Effect of treatment on the (A) Discrimination Index (DI) and (B) Recognition Index (RI) of aged hypertensive animals, at different time points after ischemic insult (n=8–10 animals/group). Symbols and error bars indicate mean and SEM. Repeated measures ANOVA, mixed models, were used to examine differences in outcomes, between the three groups over time with post hoc pair-wise comparisons denoted by *P<0.0042, the Bonferroni adjusted alpha.
Fig. 6
Fig. 6. Effect of RAS modulator treatment on spatial reference memory of aged hypertensive animals with mild cerebral hypoperfusion
Spatial reference memory evaluated with the Morris Water Maze probe test in aged SHRs. The platform was removed and rats were allowed to swim for 60 s in an attempt to find it. Performance was evaluated by measuring (A) initial latency to the target zone as well as (B) time spent in the target zones. (C) Heat maps illustrating relative time spent in the various locations during the probe tests both before (pre-probe) as well as 4 weeks after (pre-probe) after initial ischemic procedure. The target (NE) quadrant is indicated with black lines (n=8–10 animals/group). Symbols and error bars indicate mean and SEM. Repeated measures ANOVA, mixed models, were used to examine differences in outcomes between the three groups over time with post hoc pair-wise comparisons denoted by *P<0.0056, the Bonferroni adjusted alpha.
Fig. 7
Fig. 7. Effect of RAS modulator treatment on cognitive flexibility/new learning in aged hypertensive animals with mild cerebral hypoperfusion
Cognitive flexibility and “new” learning was assessed by the reversal training/test. Performance was evaluated by measuring (A) Latency to target quadrant (B) Latency to target/platform zone (C) Distance to platform zone, which is how close they swim to target location while attempting to find it (D) Duration in target zone (E) Duration in previous quadrant, which indicates preservative behavior in aged hypertensive animals and (F) Heat maps illustrating relative time spent in the various locations during the reversal, the target (SE) quadrants is indicated with black lines (n = 8–10 animals/group). Bars and error bars indicate mean and SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P<0.05.
Fig. 7
Fig. 7. Effect of RAS modulator treatment on cognitive flexibility/new learning in aged hypertensive animals with mild cerebral hypoperfusion
Cognitive flexibility and “new” learning was assessed by the reversal training/test. Performance was evaluated by measuring (A) Latency to target quadrant (B) Latency to target/platform zone (C) Distance to platform zone, which is how close they swim to target location while attempting to find it (D) Duration in target zone (E) Duration in previous quadrant, which indicates preservative behavior in aged hypertensive animals and (F) Heat maps illustrating relative time spent in the various locations during the reversal, the target (SE) quadrants is indicated with black lines (n = 8–10 animals/group). Bars and error bars indicate mean and SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P<0.05.
Fig. 8
Fig. 8. Effect of RAS modulator treatment on brain structure in aged hypertensive animals with mild cerebral hypoperfusion using Magnetic Resonance Imaging (MRI)
Representative T2-weighted (T2W) (A) coronal trans-axial MRI slices and (B) axial whole brain images of the different treatment groups compared to young normotensive wistar control (C) Coronal trans-axial FLAIR images of the 3 treatment groups. Relative measures of brain damage/atrophy (D) Total brain volume (E) Hippocampal volume (F) Ventricular volume (H) Representative trans-axial FLAIR images (G) White matter hyperintensities (WMH). The yellow arrows indicate those affecting the periventricular white matter tracks; the red arrows indicate those affecting the lateral septal nucleus in addition to the dorsal and intermediate portions. (n =3–5 animals/group). Error bars indicate SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P < 0.05.
Fig. 8
Fig. 8. Effect of RAS modulator treatment on brain structure in aged hypertensive animals with mild cerebral hypoperfusion using Magnetic Resonance Imaging (MRI)
Representative T2-weighted (T2W) (A) coronal trans-axial MRI slices and (B) axial whole brain images of the different treatment groups compared to young normotensive wistar control (C) Coronal trans-axial FLAIR images of the 3 treatment groups. Relative measures of brain damage/atrophy (D) Total brain volume (E) Hippocampal volume (F) Ventricular volume (H) Representative trans-axial FLAIR images (G) White matter hyperintensities (WMH). The yellow arrows indicate those affecting the periventricular white matter tracks; the red arrows indicate those affecting the lateral septal nucleus in addition to the dorsal and intermediate portions. (n =3–5 animals/group). Error bars indicate SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P < 0.05.
Fig. 8
Fig. 8. Effect of RAS modulator treatment on brain structure in aged hypertensive animals with mild cerebral hypoperfusion using Magnetic Resonance Imaging (MRI)
Representative T2-weighted (T2W) (A) coronal trans-axial MRI slices and (B) axial whole brain images of the different treatment groups compared to young normotensive wistar control (C) Coronal trans-axial FLAIR images of the 3 treatment groups. Relative measures of brain damage/atrophy (D) Total brain volume (E) Hippocampal volume (F) Ventricular volume (H) Representative trans-axial FLAIR images (G) White matter hyperintensities (WMH). The yellow arrows indicate those affecting the periventricular white matter tracks; the red arrows indicate those affecting the lateral septal nucleus in addition to the dorsal and intermediate portions. (n =3–5 animals/group). Error bars indicate SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P < 0.05.
Fig. 9
Fig. 9. Effect of RAS modulator treatment on Aβ1-42 concentrations in the pre-frontal cortex of aged hypertensive animals with mild cerebral hypoperfusion
Quantitative determination of Aβ1-42 concentrations in cortical lysates of aged hypertensive animals, comparing the different treatment groups at 8 weeks post-UCCAO (n = 8–9 animals/group). Error bars indicate SEM. A one-way ANOVA was used to examine differences between the groups and a Tukey-Kramer multiple comparison test was used to examine post hoc pair-wise differences. Statistical significance for post hoc comparisons using Tukey’s multiple comparison procedure are denoted by *P<0.05.

References

    1. Rouch L, Cestac P, Hanon O, Cool C, Helmer C, Bouhanick B, Chamontin B, Dartigues JF, Vellas B, Andrieu S. Antihypertensive drugs, prevention of cognitive decline and dementia: A systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs. 2015;29:113–130. - PubMed
    1. Liu W, Yamashita T, Kurata T, Kono S, Hishikawa N, Deguchi K, Zhai Y, Abe K. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats. Neurological Research. 2015;37:491–501. - PubMed
    1. López-Gil X, Amat-Roldan I, Tudela R, Castañ A, Prats-Galino A, Planas AM, Farr TD, Soria G. DWI and complex brain network analysis predicts vascular cognitive impairment in spontaneous hypertensive rats undergoing executive function tests. Frontiers in Aging Neuroscience. 2014;6:1–33. - PMC - PubMed
    1. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2013;42:2672–2713. - PMC - PubMed
    1. Gorelick PB, Nyenhuis D. Understanding and treating vascular cognitive impairment. Continuum (Minneapolis Minn) 2013;19:425–37. - PMC - PubMed

Publication types

MeSH terms